Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Reed F Beall"'
Autor:
Saania Tariq, Dana Lee Olstad, Reed F Beall, Eldon Spackman, Lorraine Lipscombe, Sharlette Dunn, Bonnie M Lashewicz, Meghan J Elliott, David JT Campbell
Publikováno v:
Public Health Nutrition, Vol 27 (2024)
Abstract Objective: FoodRx is a 12-month healthy food prescription incentive program for people with type 2 diabetes (T2DM) and experiences of household food insecurity. In this study, we aimed to explore potential users’ prospective acceptability
Externí odkaz:
https://doaj.org/article/32a1ec6eaa364234b51c7479302ee6e2
Publikováno v:
PLoS Medicine, Vol 20, Iss 11, p e1004309 (2023)
BackgroundInsulin is the primary treatment for type 1 and some type 2 diabetes but remains costly in the United States, even though it was discovered more than a century ago. High prices can lead to nonadherence and are often sustained by patents and
Externí odkaz:
https://doaj.org/article/bd6cc0c9018f4791a29e4724b302775c
Publikováno v:
PLoS ONE, Vol 16, Iss 10, p e0258013 (2021)
BackgroundThe private versus public contribution to developing new health knowledge and interventions is deeply contentious. Proponents of commercial innovation highlight its role in late-stage clinical trials, regulatory approval, and widespread dis
Externí odkaz:
https://doaj.org/article/e45fe741b7bf4d2284cc8e2b27d3bdc8
Publikováno v:
Globalization and Health, Vol 13, Iss 1, Pp 1-9 (2017)
Abstract Background This article is based upon data gathered during a study conducted in partnership with the World Intellectual Property Organization on the patent status of products appearing on the World Health Organization’s 2013 Model List of
Externí odkaz:
https://doaj.org/article/03d3dd8128e6443bba05da7cc174cb07
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0148939 (2016)
BACKGROUND:Not all new drug products are truly new. Some are the result of marginal innovation and incremental patenting of existing products, but in such a way that confers no major therapeutic improvement. This phenomenon, pejoratively known as "ev
Externí odkaz:
https://doaj.org/article/a326c736c8d643cd84d85c2bb979dba7
Publikováno v:
Nature Biotechnology. 40:1319-1325
Publikováno v:
Canadian Medical Association Journal. 194:E801-E806
In March 2020, the Government of Canada introduced measures to reduce intensifying shortages of prescription drugs during the beginning of the COVID-19 pandemic. We sought to assess the extent to which a decline in drug shortages was observed in the
Publikováno v:
Health Affairs. 41:787-796
Publikováno v:
Nature Biotechnology. 40:22-25
Autor:
Reed F. Beall, Alexander A. Leung, Amity E. Quinn, Charleen Salmon, Tayler D. Scory, Lauren C. Bresee, Paul E. Ronksley
Publikováno v:
Journal of clinical hypertension (Greenwich, Conn.). 24(10)
In this study on medication adherence among newly diagnosed patients with uncomplicated, incident hypertension, we conducted a retrospective cohort study using available administrative and laboratory data from April 1, 2012 to March 31, 2017 in Alber